Crude Oil (CL)

Dernières nouvelles pour Colgate-Palmolive (NYSE:CL) Stock

COLGATE-PALMOLIVE CO

Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Colgate-Palmolive Co

Core One Labs Inc

CHINA LIAONING DINGXU ECO by China Liaoning Dingxu Ecological Agriculture Development, Inc.

China Liaoning Dingxu Ecological Agriculture Development Inc

Clarus Corp

CHAVANT CAPITAL ACQUISITION CORP UNIT 1 COM & 1/3 WT EXP

CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC.

Claritas Pharmaceuticals Inc

Core Laboratories Inc

CALBEE Inc

Columbia Financial Inc

CALIBER ENERGY INC by Caliber Energy, Inc.

Colombier Acquisition Corp. II Class A Ordinary Shares

Colombier Acquisition Corp II

Colombier Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant

Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share

Cellebrite DI Ltd

CHRISTINA LAKE CANNABIS by Christina Lake Cannabis Corp.

Christina Lake Cannabis Corp

CLICKS GROUP LTD S/ADR by Clicks Group Ltd

Clicks Group Ltd

CENTRAL CHINA SECS S/ADR by Central China Securities Co. Ltd.

Calcol Inc

Sinch AB

Cool Co Ltd

CEL CORP by CEL CORP.

Cell Source Inc

CapitaLand China Trust

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics Inc

Direxion Daily Cloud Computing Bull 2X Shares

Chatham Lodging Trust (REIT) Common Shares of Beneficial Interest

Chatham Lodging Trust

Chatham Lodging Trust (REIT) 6.625% Series A Cumulative Redeemable Preferred Shares of Beneficial Interest

Cloud3 Ventures Inc Ordinary Shares (Sub Voting)

CLOUD3 VENTURES INC by Cloud3 Ventures Inc.

Cloud3 Ventures Inc

Calidi Biotherapeutics Inc Warrants (01/01/9999)

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics Inc

Coles Group Ltd

COLES GROUP LTD UNSP/ADR by Coles Group Ltd.

China Liberal Education Holdings Ltd Ordinary Shares

CHINA LIBERAL ED HLDG INC by China Liberal Education Holdings Limited

China Liberal Education Holdings Ltd

CONCRETE LEVELING SYS INC by Concrete Leveling Systems Inc.

Concrete Leveling Systems Inc

Cleveland-Cliffs Inc

Clearfield Inc

CLIFFORD MDERN IVING HLD by CLIFFORD MODERN LIVING HLDGS LTD.

CLARITY METALS CORP by Clarity Metals Corp.

Clarity Metals Corp

Aris Mining Corp

CLEGHORN MINERALS ORD by Cleghorn Minerals

Cleghorn Minerals Ltd

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

CLEANGO INNOVATIONS INC by CleanGo Innovations Inc.

CleanGo Innovations Inc

CLEAN SEED CAP GROUP LTD by Clean Seed Capital Group Ltd

Clean Seed Capital Group Ltd

Cloud Nine Web3 Technologies Inc

HUTECH21 CO LTD NEW by Hutech21 Co., Ltd.

Clean Harbors Inc

ClearDAO

CLST Holdings Inc

COLTENE HOLDING AG ORD by Coltene Holding AG

Coltene Holding AG

Tidal Trust II Veridien Climate Action ETF

Energy Plug Technologies Corp

CORDLIFE GROUP LTD ORD by Cordlife Group Ltd

Cordlife Group Ltd

CLS HOLDINGS PLC ORD by CLS Holdings Plc.

CLS Holdings PLC

Click Holdings Ltd

CAPITALAND INVESTMENT LTD by Capitaland Investment Ltd.

CapitaLand Investment Ltd

CLEAN EARTH ACQUISITIONS CORP RT

CLEAN EARTH ACQUISITIONS CORP UNIT 1 CL A COM & 1 RT 1/2 RED WT EXP

CLEAN EARTH ACQUISITIONS CORP RED WT EXP

Global X Funds Global X 1-3 Month T-Bill ETF

ClearSign Technologies Corporation - Common Stock

ClearSign Technologies Corp

CLEARFORD WATER SYS INC by Clearford Water Systems, Inc.

Clearford Water Systems Inc

ClickStream Corp

CITY OF LONDON INVST GRP by City of London Investment Group PLC

City of London Investment Group PLC

ProShares Long Online/Short Stores ETF

Clarke Inc

Calcitech Ltd

TWC ENTERPRISES LTD ORD by TWC Enterprises Ltd.

TWC Enterprises Ltd

CLAYTON & LAMBERT MFG CO by Clayton & Lambert Manufacturing Co.

CHALLENGER GOLD LIMITED by Challenger Gold Limited

Challenger Gold Ltd

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

BICO Group AB

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

CELLNEX TELECOM UNSP/ADR by Cellnex Telecom SA

Cellnex Telecom SA

Cellectis S.A. - American Depositary Shares

Cellectis SA

CALLINEX MINES INC by Callinex Mines Inc.

Callinex Mines Inc

Cornerstone Strategic Investment Fund, Inc. Common Shares

Cornerstone Strategic Value Fund Inc

Climb Global Solutions, Inc. - Common Stock

Climb Global Solutions Inc

CALIMA ENERGY LTD NEW by Calima Energy Ltd.

Calima Energy Ltd

CALGRO M3 HOLDINGS LTD by Calgro M3 Holdings Ltd.

Calgro M3 Holdings Ltd

Climeon AB ass B

Climeon AB

CANADIAN PREM SAND by Canadian Prem Sand Inc.

Canadian Premium Sand Inc

Calumet Inc

Clean Energy Fuels Corp

CALIAN GROUP LTD ORD by Calian Group Ltd.

Calian Group Ltd

Clene Inc

IndexIQ ETF Trust NYLI Cleaner Transport ETF

CLEAN VISION CORPORATION by Clean Vision Corporation

Clean Vision Corp

CELLNEX TELECOM SA ORD by Cellnex Telecom SA

Callisto - United States Dollar

iShares AAA CLO Active ETF

Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) unveiled a sweeping overhaul on Thursday at the 2025 Deutsche Bank Global Consumer <a target="_blank" href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0000080424/995e4954-0a90-46da-8215-51b98f42f344.html" rel="noreferrer noopener">Conference</a>. It outlined a strategy to simplify operations and sharpen its focus on core growth areas.
The move is part of a broader effort to boost efficiency and enhance long-term value for shareholders.
The restructuring plan includes cost-cutting initiatives and the elimination of up to 7,000 roles, primarily targeting non-manufacturing functions.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45789179/top-3-consumer-stocks-youll-regret-missing-this-quarter." rel="noreferrer noopener">Top 3 Consumer Stocks You&#8217;ll Regret Missing This Quarter</a>
P&amp;G anticipates taking pre-tax charges ranging between $1 billion and $1.6 billion over the next two fiscal years, with about 25% of those being non-cash charges tied to asset write-downs.
Procter &amp; Gamble intends to streamline its portfolio by divesting underperforming brands and exiting select markets. It also plans to revamp its supply chain using automation and digital tools while reducing organizational layers to cut overhead and reinvest in brand development.
For <a target="_blank" href="https://www.benzinga.com/25/04/44984872/gillette-parent-procter-gamble-slides-on-q3-sales-decline-lowered-outlook" rel="noreferrer noopener">the third quarter</a>, the company&#8217;s organic revenue climbed 5%, driven mainly by pricing strategies. Net income grew 8% to $8.6 billion, while GAAP earnings per share reached $3.49. Core EPS rose 4% to $3.81, and free cash flow productivity remained above 100%.
P&amp;G expects flat all-in sales and 2% organic growth for fiscal 2025. It lowered adjusted EPS guidance and forecasted $200 million in headwinds from commodities and forex. Dividend and buyback plans remain unchanged.
Related: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45020318/what-is-the-tariff-risk-for-procter-gamble-analyst-calculates-trims-outlook" rel="noreferrer noopener">What Is The Tariff Risk For Procter &amp; Gamble? Analyst Calculates, Trims Outlook</a>
P&amp;G also flagged external risks, including inflation, currency volatility, and global geopolitical issues. Yet the company expressed confidence in its long-term growth outlook, pointing to rising e-commerce demand, ongoing innovation in premium offerings, and increased exposure to developing markets.
Related ETFs: Consumer Staples Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>), Vanguard Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>).
Price Action: PG shares are trading lower by 0.15% to $165.70 premarket at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/asia/25/06/45791216/citi-to-cut-3500-tech-jobs-in-china-in-global-restructuring-spree" target="_blank" rel="noreferrer noopener">Citi To Cut 3,500 Tech Jobs In China In Global Restructuring Spree</a></li>
</ul>
Photo via Shutterstock

News

Procter & Gamble To Eliminate 7,000 Roles, Divest Brands In New Restructuring Strategy

Jim Cramer thinks that the bond market now offers a clearer risk-reward trade-off than so-called "safety" stocks, warning that rising 10-year Treasury yields and a political "wild card" in Washington make even dividend stalwarts feel shaky.
What Happened: The 10-year Treasury yield's jump to its highest level in more than a month has tightened the spread between bond payouts and blue-chip dividends, dulling the appeal of AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), Cramer <a href="https://www.cnbc.com/2025/05/14/jim-cramer-explains-why-its-hard-to-own-usual-safety-stocks-here.html">told</a> CNBC&#8217;s &#8216;Mad Money&#8217; viewers on Wednesday.
"In a very uncertain tape for what <a href="https://www.benzinga.com/content/44809259/3-safe-dividend-stocks-as-investors-seek-to-reset-diversification">used to be called</a> ‘safety stocks,' I'd rather just own a piece of paper like the 10-year Treasury, where, if worst comes to worst, at least I get my money back," Cramer said.
Cramer flagged Robert F. Kennedy Jr., newly installed as Health and Human Services secretary, as an <a href="https://www.benzinga.com/markets/equities/24/11/42254495/trumps-hhs-pick-rfk-jr-has-a-long-history-of-challenging-global-health-policies">unpredictable force</a> who could clamp down on pharmaceutical pricing and food additives. "Investors don't know whether Kennedy will act in favor of the companies he's tasked with regulating," he cautioned.
See also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45426516/chuck-schumer-says-trump-is-letting-cartel-members-into-the-us-asks-how-much-memecoin-did-they-pay">Chuck Schumer Says Trump Is &#8216;Letting Cartel Members&#8217; Into The US, Asks How Much &#8216;Memecoin&#8217; Did They Pay</a>
What To Know: That uncertainty compounds existing headaches. Johnson &amp; Johnson is <a href="https://www.benzinga.com/general/biotech/25/04/44586129/us-judge-rejects-another-johnson-johnson-attempt-to-use-bankruptcy-for-talc-cancer-claims">still wrestling</a> with talc-related lawsuits that have already cost billions in settlements and reserves, a cloud Wall Street <a href="https://www.benzinga.com/25/04/44920880/expert-flags-never-before-observed-trio-falling-stocks-and-short-yields-bucking-rising-long-yields-nothing-is-normal-about-this">fears could grow</a> heavier if bond yields <a href="https://www.benzinga.com/25/05/45399783/gordon-johnson-warns-of-potential-liberation-day-20-as-30-year-treasury-yields-approach-5-amid-dollar-weakness?utm_source=chatgpt.com">keep luring</a> income-seekers away. AbbVie's rich dividend likewise looks less generous when a risk-free Treasury pays nearly the same rate with zero headline risk.
Consumer staples aren't immune either, says Cramer. Procter &amp; Gamble and Colgate boast recession-proof brands, yet their 2–3% yields no longer tower over Treasuries, and Cramer said "the yields may simply not be high enough to justify the risk."
Snack titan PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) and cereal maker General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) could also <a href="https://www.benzinga.com/government/regulations/24/11/42144709/kennedys-war-on-food-dyes-could-be-coming-to-your-breakfast-table">come under fire</a> if Kennedy pushes to restrict artificial colors and other additives, Cramer warned, asking rhetorically whether kids would still eat Lucky Charms without its rainbow marshmallows.
Why It Matters: For now, Cramer said he is "tempted to buy General Mills" on weakness, but fears Washington's next pitch more than the stock's upside.
Cramer also told "Mad Money" viewers that recession worries can be a buying opportunity, saying high-quality retailers look cheap so long as you don't think the economy will "fall off a cliff." Despite earlier warning, the sector was in the trade-war "blast radius," he now does have a <a href="https://www.benzinga.com/25/05/45416455/jim-cramer-says-these-retail-stocks-rl-gap-can-survive-a-market-correction">couple of clear favorites</a> to scoop up on any dip.
Benzinga Edge Stock Rankings indicate Johnson &amp; Johnson has a Momentum in the 47th percentile and Growth in the 63rd, how do other &#8220;safety&#8221; stocks rank in terms of these metrics? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Check them out here</a>.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="442" height="282" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33.png" alt="" class="wp-image-915950" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33.png 442w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15010652/Screenshot-2025-05-15-at-14.06.33-300x191.png 300w" sizes="(max-width: 442px) 100vw, 442px" /></figure>
Photo courtesy: katz / Shutterstock.com
Read next: <a href="https://www.benzinga.com/general/travel/25/05/45427289/peter-schiff-warns-qatars-200-billion-boeing-deal-could-spike-us-inflation-interest-rates-says-treasury-sell-off-may-follow">Peter Schiff Warns Qatar&#8217;s $200 Billion Boeing Deal Could Spike US Inflation, Interest Rates — Says Treasury Sell-Off May Follow</a>

Equities

Markets

ABBV

Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets

Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) posted better-than-expected first-quarter FY25 <a href="https://www.benzinga.com/quote/CL/earnings">earnings on Friday</a>.
The company&#8217;s first-quarter FY25 sales declined 3% year over year to $4.91 billion, beating the analyst consensus estimate of $4.86 billion. Non-GAAP EPS of $0.91 beat the consensus estimate of $0.86.
&#8220;As we look ahead, uncertainty and volatility in global markets, including the impact of tariffs, remain challenging. We are confident in our strategy and will continue to execute with focus and agility to mitigate these factors and achieve our revised 2025 financial targets,&#8221; said Chairman, President, and CEO Noel Wallace.
For FY25, Colgate said it expects net sales to be up in the low single digits, including a negative impact from foreign exchange in the low single digits. The company anticipates organic sales growth to be 2% to 4%.
Colgate shares fell 3% to trade at $91.08 on Monday.
These analysts made changes to their price targets on Colgate following earnings announcement.
<ul>
<li>JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 to $103.</li>
<li>Citigroup analyst Filippo Falorni maintained Colgate-Palmolive with a Buy and raised the price target from $103 to $108.</li>
</ul>
Considering buying CL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-1024x560.png" alt="" class="wp-image-891420" style="width:532px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/28125653/image-200.png 1172w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>

Earnings

Price Target

Analyst Ratings

Trading Ideas

Colgate-Palmolive Analysts Increase Their Forecasts After Upbeat Results

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Buy and raises the price target from $103 to $108.

Citigroup Maintains Buy on Colgate-Palmolive, Raises Price Target to $108

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight and raises the price target from $95 to $103.

JP Morgan Maintains Overweight on Colgate-Palmolive, Raises Price Target to $103

After months of sluggish performance, cannabis stocks finally caught a break. Federal reform chatter—this time involving Donald Trump—helped fuel a rally across the sector. But even with this uptick, analysts are urging caution.
Beyond the markets, the global cannabis map keeps evolving: Portugal has quietly become Europe's biggest exporter, Spain banned HHC and Argentina passed a sweeping "anti-mafia" law raising concerns for patients and cannabis activists. Meanwhile, California cities slash taxes to save local stores and a cult rolling paper brand opened its factory doors to the public for the first time ever.
Let's dive in.
<h2 class="wp-block-heading">Politics And Policy</h2>
<h3 class="wp-block-heading">Trump Reportedly Pushing For SAFE Banking Reform</h3>
The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) closed the week up 9.7% after reports that Trump is privately encouraging lawmakers to pass banking reform ahead of the 2026 midterms. Analysts say the rally is likely technical unless public support follows.
Read more on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp">Benzinga</a>
<h3 class="wp-block-heading">Argentina's New Anti-Mafia Law Raises Civil Rights Concerns</h3>
Passed last month, Argentina&#8217;s new law allows authorities to detain suspects, seize property and wiretap phones without judicial approval in designated zones. Experts fear the law could be used to target medical cannabis users and community organizations.
Read more on <a class="" href="https://elplanteo.com/ley-antimafia-argentina/">El Planteo</a>
<h3 class="wp-block-heading">Hungary Ramps Up Drug War Ahead of Elections</h3>
Hungary is pushing a constitutional amendment to criminalize drug use and give law enforcement broader powers. Critics say the government is using prohibitionist rhetoric to boost voter support.
Read more on <a class="" href="https://elplanteo.com/hungria-guerra-drogas/">El Planteo</a>
<h3 class="wp-block-heading">Spain Bans HHC And Other Semi-Synthetic Cannabinoids</h3>
Spain added HHC and several related compounds to its list of controlled substances, effectively banning their sale and distribution nationwide.
Read more on <a class="" href="https://elplanteo.com/espana-prohibe-hhc-cannabinoides/">El Planteo</a>
<h3 class="wp-block-heading">Portugal Nearly Triples Cannabis Exports</h3>
Portugal exported 32,558 kilos of cannabis in 2024, a 172% increase over the prior year. It now ranks as the largest cannabis exporter in Europe and second globally behind Canada.
Read more on <a class="" href="https://www.theportugalnews.com/news/2025-04-24/portugal-cannabis-exports-almost-triple/97136">The Portugal News</a>
<h2 class="wp-block-heading">Markets And Stocks</h2>
<h3 class="wp-block-heading">Body And Mind Sells Long Beach Dispensary For $856K</h3>
Body and Mind Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/BAMM#CSE">BAMM</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMMJ#OTC">BMMJ</a>) is divesting its Long Beach location for $856,250. The company is shifting its focus to retail expansion in Illinois and New Jersey.
<h3 class="wp-block-heading">Green Market Report Closes Its Doors</h3>
Green Market Report, one of the few cannabis-focused financial news outlets, has shut down. Founder Debra Borchardt confirmed that Crain Communications, which acquired the site in 2022, decided to discontinue operations. All staff members have been laid off except veteran journalist John Schroyer, who will remain at Crain to cover cannabis and other sectors.
The closure is a major loss for the industry—and a stark reminder of how vulnerable cannabis media remains. With few specialized outlets left standing, supporting independent reporters and sector-specific journalism is more essential than ever. Generalist coverage often misses the nuance, science and community insight that cannabis reporting requires.
If you wonder how you can support your favorite media outlets and journalists, <a href="mailto:javierhasse@benzinga.com">email me</a>.
<h2 class="wp-block-heading">Culture And Commentary</h2>
<h3 class="wp-block-heading">Inside The RAW Factory: Where Iconic Papers Are Born</h3>
In a rare behind-the-scenes look, Benzinga visited RAW's Spanish production site in Benimarfull. Founder Josh Kesselman walked us through the machines, secrecy and craftsmanship behind the world's most famous rolling paper brand.
Read more on <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44992856/willy-wonka-of-weed-opens-the-doors-to-the-raw-factory-heres-what-we-saw">Benzinga</a>
Watch the <a href="https://www.youtube.com/watch?v=6TRFUO4_Yng">video</a> below:
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The WILLY WONKA OF WEED Opened The Doors To The RAW Factory: Here's What We Saw" width="500" height="281" src="https://www.youtube.com/embed/6TRFUO4_Yng?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h2 class="wp-block-heading">Business And Brands</h2>
<h3 class="wp-block-heading">Curaleaf Debuts Anthem Pre-Roll Brand</h3>
Curaleaf Holdings, Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) launched a new pre-roll brand, Anthem, now available in New York, New Jersey, Illinois, and Massachusetts. Additional state launches are planned for summer.
<h3 class="wp-block-heading">Wynk Expands Into Four More States</h3>
Hemp seltzer brand Wynk is now available in Kentucky, Arkansas, Alabama and Wisconsin—building on its presence in New Jersey, Texas and Florida. The company has secured major retail placements and distributor partnerships in each new state.
<h3 class="wp-block-heading">Humboldt Seed Co. Releases OG Triploid Autoflower Strain</h3>
Humboldt Seed Company launched an OG triploid autoflower strain boasting 30–34% THC and fast flowering times. It's non-GMO and bred for outdoor cultivators looking to match indoor potency and yield.
<h2 class="wp-block-heading">Industry And Infrastructure</h2>
<h3 class="wp-block-heading">Cresco Labs Opens $15M Cultivation Facility In Kentucky</h3>
Cresco Labs (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#CSE">CL</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) cut the ribbon on a $15.4 million facility in Winchester, KY. The site is expected to be operational by year-end and will support the state's newly launched medical cannabis program.
<h3 class="wp-block-heading">California Cities Slash Taxes As Stores Struggle</h3>
Cities across the Coachella Valley—including Desert Hot Springs and Palm Springs—are reducing cannabis taxes in response to widespread retail closures. Sonoma County followed suit, while San Diego and the state move in the opposite direction.
Read more on <a class="" href="https://www.sfgate.com/cannabis/article/california-cannabs-tax-rates-fall-20281817.php">SFGate</a>
<h2 class="wp-block-heading">Recommended Reads</h2>
<a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/24/carmelo-anthonys-cannabis-mission-comes-home-i-know-the-door-i-hold-open/">Carmelo Anthony's Cannabis Mission Comes Home: ‘I Know The Door I Hold Open'</a> NBA legend Carmelo Anthony opens up about cannabis advocacy, business ownership and legacy-building in New York.
<a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/22/is-america-missing-out-on-the-global-cannabis-boom/">Is America Missing Out On The Global Cannabis Boom?</a> As Europe, Latin America, Asia and Africa expand cannabis markets, U.S. inaction threatens its leadership position globally.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/45018519/how-local-opposition-threatens-long-islands-cannabis-market-and-what-that-means-for-investors">How Local Opposition Threatens Long Island&#8217;s Cannabis Market And What That Means For Investors</a> Local bans and delays are creating major hurdles for New York's cannabis rollout—especially in suburban strongholds.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44957196/these-are-the-cannabis-industrys-power-players-according-to-forbes">These Are The Cannabis Industry&#8217;s Power Players, According To Forbes</a> Forbes unveils its latest list of top cannabis executives, entrepreneurs and advocates shaping the industry's future.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44956994/145-years-later-zig-zag-gets-loud-about-weed-with-times-square-takeover">145 Years Later, Zig-Zag Gets Loud About Weed With Times Square Takeover</a> The iconic rolling paper brand embraces cannabis culture with a bold advertising splash in the heart of New York.
<a class="" href="https://www.benzinga.com/25/04/44934689/snoop-doggs-last-dance-is-cannabis-cinema-at-its-weirdestand-its-got-funkadelic-dad-rock-counterpart">Snoop Dogg&#8217;s &#8216;Last Dance&#8217; Is Cannabis Cinema At Its Weirdest—And There&#8217;s A Funkadelic &#8216;Dad Rock&#8217; Counterpart</a> Snoop Dogg releases a psychedelic music video tribute to cannabis culture.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44929611/why-pre-rolls-are-cannabis-most-profitable-format-from-california-to-canada">Why Pre-Rolls Are Cannabis&#8217; Most Profitable Format, From California To Canada</a> Pre-rolls are dominating retail shelves and margins, solidifying their status as the cannabis industry&#8217;s breakout category.
That's it for this week. See you next Friday with another roundup of what's shaping the cannabis world—on Wall Street, in Washington and around the globe.

Cannabis

Politics

BMMJ

CRLBF

CSE:BAMM

CSE:CL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

MSOS

TSX:CURA

This Week In Cannabis: Trump's Reform Buzz Drives Stocks Up, RAW's Secret Factory, Global Shifts And More

Wall Street's three-day rally came to a pause on Friday, with major indices hovering near the flatline by midday in New York as caution returned amid mixed signals on <a href="https://www.benzinga.com/news/global/25/04/45004954/china-reportedly-begins-exempting-key-us-imports-from-tariffs-including-pharma-and-aerospace-parts">U.S.-China trade relations.</a>
President Donald Trump claimed to have held a phone call with President Xi Jinping, yet Chinese officials denied that any talks had taken place.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) extended its rally into a fourth consecutive session, notching its best weekly performance of the year with a 16% gain. On Thursday afternoon, Transportation Secretary Sean Duffy introduced a new regulatory framework for self-driving vehicles, saying it aimed to reduce bureaucratic hurdles and advance toward a unified national standard.
T-Mobile US Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NYSE">TMUS</a>) was the biggest laggard of the day, falling 11%, on track for its worst single-day loss since March 2020. This came despite better-than-expected earnings, as its core wireless business posted slower growth than analysts had projected.
Among sectors, consumer discretionary led gains, buoyed by Tesla's 8% gain, while materials underperformed.
In fixed income, Treasury yields declined for a fourth straight session, underscoring how critical Trump's early-week reassurance — that he would not dismiss Fed Chair Jerome Powell — was for bond market sentiment.
The yield on the 10-year Treasury note dropped 4 basis points to 4.27%, on course for its lowest close since April 8.
In commodities, gold slid 2%, oil held steady at $62 per barrel, and natural gas rose 1% to $3 per million British thermal units, snapping a 10-session losing streak.
In crypto markets, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose 1.2% to $95,000.
<h2 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,250.90</td>
<td>+0.2%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,488.71</td>
<td>+0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,908.60</td>
<td>-0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,942.82</td>
<td colspan="2">-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) flattened at $546.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.5% to $399.23.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;fell 0.2% to $468.61.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.7% to $192.79.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 1.1%; the&nbsp;Materials Care&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
Stocks reacting to earnings report included:
<ul>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): up 1.7%</li>
<li>T-Mobile US Inc.: down 10.9%</li>
<li>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>): up 2.4%</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>): down 7.2%</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): down 3.2%</li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>): down 11.0%</li>
<li>Republic Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>): down 0.2%</li>
<li>Digital Realty Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>): up 3.0%</li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>): down 5.2%</li>
<li>Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>): up 10.3%</li>
<li>The Hartford Financial Services Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>): down 1.1%</li>
<li>Weyerhaeuser Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>): down 2.1%</li>
<li>Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>): up 1.1%</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>): down 7.7%</li>
<li>LyondellBasell Industries N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>): up 0.0%</li>
<li>VeriSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>): up 9.1%</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>): down 2.0%</li>
<li>Carrier Global Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>): down 0.5%</li>
<li>Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>): down 0.7%</li>
<li>Erie Indemnity Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>): down 11.8%</li>
<li>Principal Financial Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>): down 1.4%</li>
<li>Eastman Chemical Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>): down 6.0%</li>
<li>Healthpeak Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOC#NYSE">DOC</a>): down 4.7%</li>
</ul>
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45009066/goldman-sachs-upgrades-charles-schwab-to-buy-one-of-the-best-earnings-growth-outlooks-analyst-says">Goldman Sachs Upgrades Charles Schwab To Buy: &#8216;One Of The Best Earnings Growth Outlooks,&#8217; Analyst Says</a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

CARR

CHTR

SPDR Dow Jones Industrial Average ETF Trust

ERIE

GILD

GOOGL

INTC

TMUS

TSLA

VRSN

Select Sector SPDR-Consumer Discretionary

Wall Street Rally Pauses, Tesla Heads For Strongest Week In 6 Months: What's Driving Markets Friday?

Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) shares are <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45004176/colgate-announces-1st-quarter-2025-results" rel="noreferrer noopener">trading higher in premarket</a> on Friday after the first-quarter FY25 earnings report.
The company's <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45004176/colgate-announces-1st-quarter-2025-results" rel="noreferrer noopener">first-quarter FY25 sales</a> declined 3% year over year to $4.91 billion, beating the analyst consensus estimate of $4.86 billion.
Organic sales increased by 1.4%. Total Oral, Personal, and Home Care net sales increased&nbsp;by&nbsp;6.8% to $3.96 billion.
Non-GAAP EPS of $0.91 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus </a>estimate of $0.86.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/04/44977669/pepsico-ceo-warns-of-tariffs-led-increase-in-supply-chain-costs-cuts-annual-profit-outlook" rel="noreferrer noopener">PepsiCo CEO Warns Of Tariffs Led ‘Increase In Supply Chain Costs,' Cuts Annual Profit Outlook</a>
Colgate's gross profit was $2.98 billion, while the margin expanded 80 basis points to 60.8%. Selling, general and administrative expenses slipped 0.9% to $1.8 billion.
Operating margin expanded 120 basis points to 21.9%, and operating income increased 2.8% to $1.07 billion for the quarter.
As of March 31, the company had $1.11 billion in cash and equivalents, and its operating cash flow totaled $600 million.
"As we look ahead, uncertainty and volatility in global markets, including the impact of tariffs, remain challenging. We are confident in our strategy and will continue to execute with focus and agility to mitigate these factors and achieve our revised 2025 financial targets," said Chairman, President, and CEO Noel Wallace.
Outlook FY25: Colgate expects net sales to be up in the low single digits, including a negative impact from foreign exchange in the low single digits.
The company anticipates organic sales growth to be 2% to 4%.
The current outlook is better from the last quarter, where <a target="_blank" href="https://www.benzinga.com//node/43385529" rel="noreferrer noopener">it expected FY25 net sales</a> to be roughly flat, including a mid-single-digit negative impact from foreign exchange.
On a non-GAAP basis, the company expects gross profit margin and advertising to be roughly flat as a percentage of net sales and earnings per share to be up in the low single digits.
Price Action: CL shares traded higher by 1.19% at $93.80 in premarket session at the last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44996394/chipotle-battles-slumping-sales-but-honey-chicken-boosts-hope-say-analysts" target="_blank" rel="noreferrer noopener">Chipotle Battles Slumping Sales, Analyst Pin Hope On Honey Chicken</a></li>
</ul>
Photo by EDSON DE SOUZA NASCIMENTO via Shutterstock

Guidance

General

Colgate-Palmolive CEO Wallace Says 'Impact Of Tariffs Remain Challenging,' But Raises Annual Revenue Outlook Slightly

Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) .

Colgate-Palmolive expects FY 2025 Net sales to be up low single digits, including a low-single-digit negative impact from foreign exchange.

Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.86 by 5.81 percent. This is a 5.81 percent increase over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $4.91 billion which beat the analyst consensus estimate of $4.86 billion by 0.95 percent. This is a 3.04 percent decrease over sales of $5.07 billion the same period last year.

Earnings Beats

Colgate-Palmolive Q1 Adj. EPS $0.91 Beats $0.86 Estimate, Sales $4.91B Beat $4.86B Estimate

U.S. stock futures traded mixed on Friday after three consecutive days of gains, with S&amp;P 500 futures edging higher amid <a href="https://benzinga.com/analyst-ratings/analyst-color/25/04/44988781/wall-street-rally-extends-into-third-day-whats-driving-markets-thursday">rising earnings optimism</a> and signs of easing U.S.-China trade tensions.
The first quarter earnings report of Google-parent Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) topped estimates, adding to investor confidence following weeks of uncertainty.
Investors will be keeping an eye on AbbVie Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>),&nbsp;HCA Healthcare Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), and&nbsp;Aon PLC&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), among several other corporate earnings that are set to be released on Friday. 
U.S. 10-Year Treasury yields stood at 4.3% and 2-Year Treasury yields at 3.80%. According to the CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a> predictions, there is a 95.3% chance of the Federal Reserve keeping interest rates unchanged during its next meeting in May.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.13%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.20%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.22%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.48%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) dipped 0.19% and 0.37%, respectively, in Friday's premarket trading, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;17jsfbw&#x2A;_gcl_au&#x2A;MjA5Njc0MjY1My4xNzQwODM2NTUw&#x2A;_ga&#x2A;R1MxLjEuMTc0NDY0ODA3Mi4yLjAuMTc0NDY0ODA3NS4wLjAuMA..&#x2A;_ga_V7ZK73W7N0&#x2A;MTc0NTU3MTI2OS4xLjEuMTc0NTU3MTQ4My4wLjAuMA..">Benzinga Pro</a> data.
Cues From Last Session: 
The markets were buoyed by the strong performance of Alphabet and T-Mobile US Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>), but several others, such as Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>), fell short of estimates.
Economic data was largely mixed on Thursday, with the Initial Jobless Claims report at 220,000, against a forecast of 222,000, while Existing Home Sales came in at 4.03 million, falling short of the median forecast at 4.13 million.
All S&amp;P 500 sectors advanced on Thursday, barring consumer staples, which declined 0.88% owing to the lackluster earnings of PepsiCo and Procter &amp; Gamble during the day.
As of Thursday, the Nasdaq 100 was down 13.5% from its previous high of 22,222.61 points, the S&amp;P 500 was down 10.8% from a high of 6147.43 points, and finally, the Dow Jones Industrial Average was down 11% from its high of 45,073.63.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>2.74%</td>
<td>17,166.04</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>2.03%</td>
<td>5,484.77</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.23%</td>
<td>40,093.40</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2.00%</td>
<td>1,957.59</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts: 
Market analyst, Ryan Detrick, highlighted the fact that the S&amp;P 500 has risen by at least 1.5% for three trading days in a row, saying that, &#8220;This isn&#8217;t stuff you see in bear market rallies or short covering rallies.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The S&amp;P 500 is up at least 1.5% for three days in a row. This isn&#39;t stuff you see in bear market rallies or short covering rallies. You see this before times of strong performance. Higher 10 out of 10 times a year later and up 21.6% on average. <a href="https://t.co/kfvfNKq6IK">pic.twitter.com/kfvfNKq6IK</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1915608371840921812?ref_src=twsrc%5Etfw">April 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;You see this before times of strong performance,&#8221; he says, &#8220;higher 10 out of 10 times a year later and up 21.6% on average,&#8221; each time you see three consecutive daily gains of 1.5% or more in the S&amp;P 500.
Upcoming Economic Data:
Here&#8217;s what investors will be looking at on Friday,
<ul>
<li>The Consumer Sentiment (Final) report is set to be released at 10 AM Eastern Time on Friday.</li>
</ul>
Stocks In Focus:
<ul>
<li>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is up 2.40% in pre-market trade as it is set to report its earnings this morning, with analysts expecting earnings of $2.40 per share, on $12.9 billion in revenue. </li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) is down 0.43% pre-market and is set to report its earnings before the bell, with analysts expecting $5.75 per share, on $18.3 billion in revenue. </li>
<li>Aon PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) is set to report its earnings prior to the opening bell and is up 1.08% pre-market. Analysts expect earnings of $6.03 per share, on $4.8 billion in revenue. </li>
<li>Colgate-Palmolive Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) is up 0.18% in pre-market trade in anticipation of its first quarter earnings prior to the opening bell. Analysts expect the FMCG giant to post $0.86 per share in earnings, on $4.8 billion in revenue. </li>
<li>Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) is down 4.8% in pre-market trade and is set to report its first quarter results before markets open. Analysts expect $8.59 per share in earnings and $13.7 billion in revenue.</li>
</ul>
Commodities, Gold And Global Equity Markets
Crude oil futures are trading down 0.68% in the early New York session on Friday, at $62.63 per barrel.
The U.S. Dollar Index (DXY) is up 0.37%, trading at 99.74, while gold spot prices continue to witness a pullback, trading at 3,299.63, down 1.08%.
Asian markets edged higher on Friday, with the Nikkei 225, Kospi, and Shenzhen ending the day in the green, along with Australia&#8217;s ASX 200. India&#8217;s Nifty 50 and the Sensex are ending the week down.
Image Via shutterstock

Comments

Colgate-Palmolive

Actualités

Dernières nouvelles pour Colgate-Palmolive (NYSE:CL) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL